BFM
MRVI icon

Boothbay Fund Management’s Maravai LifeSciences MRVI Stock Holding History

Boothbay Fund Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$156K Buy
+55,060
New +$187K ﹤0.01% 1821
2021
Q4 		– Sell
-26,300
Closed -$1.29M – 2099
2021
Q3 		$1.29M Buy
+26,300
New +$1.28M 0.04% 638

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boothbay Fund Management's MRVI Position: Q1 2026 in Review

Boothbay Fund Management opened a new position in Maravai LifeSciences (MRVI) in Q1 2026: 55,060 shares worth $156K. The stake represents ﹤0.01% of the portfolio and ranks #1821 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in MRVI as recently as Q3 2021.

Boothbay Fund Management first reported a position in MRVI in Q3 2021 and has held it in 2 quarters since. The position peaked at $1.29M in Q3 2021. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Boothbay Fund Management held 55,060 shares of Maravai LifeSciences worth $156K as of Q1 2026.
  • Maravai LifeSciences was a new Boothbay Fund Management position in Q1 2026.
  • Maravai LifeSciences made up ﹤0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1821 holding.
  • Boothbay Fund Management first reported a position in Maravai LifeSciences in Q3 2021 and has held it in 2 quarters since.
  • Boothbay Fund Management's Maravai LifeSciences position peaked at $1.29M in Q3 2021.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.